A REVIEW OF EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF ALISKIREN, A NOVEL DIRECT RENIN INHIBITOR(DRI)
Yomna Mohamed Tamim Mohamed;
Abstract
The present study suggested that aliskiren, a direct renin inhibitor (DRI), is used as an effective antihypertensive therapy both as monotherapy and in combination with more conventional blockers of the renin-angiotensin-aldosterone system (RAAS). Aliskir
Other data
| Title | A REVIEW OF EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF ALISKIREN, A NOVEL DIRECT RENIN INHIBITOR(DRI) | Other Titles | بحث مرجعى عن الدراسة التجريبية والسريرية الفارماكولوجية لعقار الألسكيرين الجديد المثبط المباشر لانزيم الرنين (مثبط الرنين المباشر | Authors | Yomna Mohamed Tamim Mohamed | Keywords | A REVIEW OF EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF ALISKIREN, A NOVEL DIRECT RENIN INHIBITOR(DRI) | Issue Date | 2010 | Description | The present study suggested that aliskiren, a direct renin inhibitor (DRI), is used as an effective antihypertensive therapy both as monotherapy and in combination with more conventional blockers of the renin-angiotensin-aldosterone system (RAAS). Aliskir |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 97372p1218.pdf | 263.27 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.